ask="66.00"
ask_size="100"
average_daily_volume="578639"
bid="64.00"
bid_size="100"
book_value="11.13"
change="+2.23"
change_from_200_day_moving_average="18.70"
change_from_50_day_moving_average="13.23"
change_from_52_week_high="-1.02"
change_From_52_week_low="38.70"
change_in_percent="+3.55%"
close="64.98"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.20"
ebitda="-132.17M"
eps_estimate_current_year="-4.37"
eps_estimate_next_quarter="-1.25"
eps_estimate_next_year="-5.21"
ex_dividend_date="N/A"
float_shares="33657000"
high="65.61"
high_52_weeks="66.00"
last_trade_date="2/17/2017"
last_trade_price="64.98"
last_trade_size="49811"
last_trade_time="4:00pm"
low="59.50"
low_52_weeks="26.28"
market_capitalization="2.42B"
moving_average_200_day="46.28"
moving_average_50_day="51.75"
name="Sage Therapeutics
Inc."
notes="N/A"
one_year_target_price="79.09"
open="60.05"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+40.40%"
percent_change_from_50_day_moving_average="+25.58%"
percent_change_from_52_week_high="-1.55%"
percent_change_from_52_week_low="+147.26%"
previous_close="62.75"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.64"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="37167000"
short_ratio="8.74"
stock_exchange="NGM"
symbol="SAGE"
volume="1840036"
weeks_range_52="26.28 - 66.00"
